Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection.
about
New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patientSentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial.Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER databaseImpact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient populationAxillary recurrences following positive sentinel lymph node biopsy with individual tumor cells or micrometastases and no axillary dissection.Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapyOptimal management of sentinel lymph node positive biopsy patients in early breast cancer.The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study.The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidenceInnovations in surgical oncology at Baylor University Medical Center.Joseph Allen Kuhn, MD: a conversation with the editorAxillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literatureWhat is the future of axillary surgery for breast cancer?Advantages of one step nucleic acid amplification (OSNA) whole node assay in sentinel lymph node (SLN) analysis in breast cancerLymphatic mapping and sentinel lymph node biopsy for breast cancer patients.Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden.Molecular markers of breast axillary lymph node metastasis.PET Probe-Guided Surgery in Patients with Breast Cancer: Proposal for a Methodological ApproachThe positive sentinel node.Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients.Relevance of the American College of Surgeons Oncology Group Z0011 Trial to breast cancer in the Australian setting.Questioning the role of axillary node dissection in sentinel node positive early stage breast cancer in the South Eastern Cancer Centre.Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1-2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000.Sentinel node biopsy and improved patient care.A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram.Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
P2860
Q26771845-9E4F6DA2-27CC-4C24-B2EE-4530A1B03BACQ31022615-9E01C5FE-0E02-4407-953B-42E40D5FA775Q33322239-A935F4C4-282C-444C-A7A1-CB810A03D814Q33705413-70824C33-D91C-448D-8063-71A11D7E7C3CQ33928258-285AD3FA-B543-41A3-AA4C-F348224D1820Q35073254-6643A8E4-DAD2-4A24-819C-F51D69458E70Q35092746-3061CD06-3A5A-47CC-A842-6D7ECBDAA1BDQ35125432-07E80DE5-4F25-46A1-9A5F-B14D1C0B8856Q35194725-66EC6B09-2EAE-4684-990A-03E2833602EEQ35603724-E8B18143-5604-4573-8A1D-0B167E6C7DF1Q36168193-E186DE87-ECAF-4005-A0BE-290EFC8EEBDDQ36190462-57DC690F-6505-4E69-B53E-EE98062F91F0Q36360305-3D96A29A-72A9-474E-A57F-52826F4F14D4Q36360316-A0E16574-1CD2-40F2-8165-EE45C47260B9Q36420776-E65562EB-5CB5-4DF0-B03D-20253700BDD5Q36863202-4AB84467-DD93-46F8-A4DB-2CFD1D27BB03Q37299755-7DC70E07-7B03-4EFF-9544-1C59AD7C066AQ37478779-D930A5C6-A52D-4868-984E-F0EFC6B179D3Q37482186-FEE6EE37-E3D5-4C74-88CD-BF5F86B0736CQ37542255-121476A4-DF60-4E15-BC9D-061994CA9AD3Q37705266-5A2AB598-CCB1-412E-B2B7-882E95686573Q37845312-B1007922-C111-44A3-85EE-B3701B35BCECQ37863619-87E0D943-62C6-4E32-BF34-E1464BE7C668Q38167328-34E478F4-2332-4A49-83E4-EB41279D0B09Q38192507-EA9A939E-83EC-4D94-965A-96EF61FB08EEQ40589453-1F34CC0B-3A77-412D-A9D8-D09550A12F74Q41354358-BBC2DC2B-6F9D-4F96-A8E3-3C0E33D2185BQ42026408-9D1BA3B5-6952-488A-85C7-029AF8B387E3Q42402618-1ECE9E49-20A7-4A1A-86AF-28A25693EF3CQ44802549-923EAE36-16BF-4002-870E-5F279759AE72Q46646028-A4574B9F-F53C-4FE7-A845-26DEAE42A1B6Q53573091-4E3738A1-BFD5-4FC6-9745-21E7A8BEE0DBQ57124745-DADE1E40-0343-4534-A553-95F857A17DCD
P2860
Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Preliminary outcome analysis i ...... declined axillary dissection.
@ast
Preliminary outcome analysis i ...... declined axillary dissection.
@en
type
label
Preliminary outcome analysis i ...... declined axillary dissection.
@ast
Preliminary outcome analysis i ...... declined axillary dissection.
@en
prefLabel
Preliminary outcome analysis i ...... declined axillary dissection.
@ast
Preliminary outcome analysis i ...... declined axillary dissection.
@en
P2093
P356
P1476
Preliminary outcome analysis i ...... declined axillary dissection.
@en
P2093
Jerri S Fant
Joseph A Kuhn
Kimberly Ridl
Michael D Grant
Ronald C Jones
Sally M Knox
Sheryl A Livingston
P2888
P304
P356
10.1245/ASO.2003.04.022
P577
2003-03-01T00:00:00Z
P6179
1004711237